Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy. [electronic resource]
Producer: 20090903Description: 1285-9 p. digitalISSN:- 1468-2060
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- blood
- Biomarkers -- blood
- C-Reactive Protein -- metabolism
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Infliximab
- Male
- Middle Aged
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.